Is this email not displaying correctly? View it in your browser.
 
Newswise - News for JournalistsNewswise - pix
Newswise Special Wire
Tuesday, February 4, 2020

Public edition | newswise.com

Newswise Cancer Research Wire for 04-Feb-2020
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.


Cancer Research


Study demonstrates liquid biopsy as effective predictor of stage III melanoma relapse and treatment

A study at The University of Texas MD Anderson Cancer Center showed that circulating tumor cells (CTCs), a form of liquid biopsy, was independently associated with melanoma relapse, suggesting CTC assessment may be useful in identifying patients at r...

– University of Texas M. D. Anderson Cancer Center

Clinical Cancer Research

Embargo expired on 03-Feb-2020 at 10:00 ET


Cold plasma patch could make immunotherapy more effective for treating melanoma, study finds

An interdisciplinary team of researchers at the UCLA Jonsson Comprehensive Cancer Center has developed a medicated patch that can deliver immune checkpoint inhibitors and cold plasma directly to tumors to help boost the immune response and kill cance...

– University of California, Los Angeles (UCLA), Health Sciences

Proceedings of the National Academy of Sciences

Embargo expired on 03-Feb-2020 at 15:00 ET


Lung Cancer Screening Decision Aid Delivered Through Tobacco Quitlines Improves Informed Decision-Making

Researchers from The University of Texas MD Anderson Cancer Center have shown that a decision aid delivered through tobacco quitlines effectively reaches a screening-eligible population and results in informed decisions about lung cancer screening.

– University of Texas M. D. Anderson Cancer Center

JAMA Network Open

Embargo expired on 31-Jan-2020 at 11:00 ET


Researchers identify possible new combination treatment for advanced melanoma

Using an immunotherapy drug in combination with an infusion of anti-tumor immune cells may produce a stronger immune response that could help fight advanced melanoma.

– University of California, Los Angeles (UCLA), Health Sciences

Nature Communications

Embargo expired on 31-Jan-2020 at 11:15 ET


Building a Safer CAR-T Therapy

A Ludwig Cancer Research study has devised a new type of chimeric antigen-receptor (CAR) T cell—a family of promising immunotherapies for cancer—that can be switched on and off on demand.

– Ludwig Cancer Research

Nature Biotechnology, Feb-2020


Study Defines How to Safely Remove Ovary in Young Girls for Best Results in Fertility Preservation

Young girls who are about to undergo treatment for cancer or other therapies that pose high risk of infertility can opt to have an ovary removed and preserved for future transplantation when they are ready to pursue pregnancy. However, the tiny ovary...

– Ann and Robert H. Lurie Children's Hospital of Chicago

Journal of Pediatric Surgery, Jan-2020


If cancer were easy, every cell would do it

A new paper puts an evolutionary twist on a classic question. Instead of asking why we get cancer, researchers at Osnabrück University and the Santa Fe Institute use signaling theory to explore how our bodies have evolved to keep us from getting mor...

– Santa Fe Institute


Assessing ‘stickiness’ of tumor cells could improve cancer prognosis

Researchers led by UC San Diego built a device that sorts and separates cancer cells from the same tumor based on how “sticky” they are. They found that less sticky cells migrate and invade other tissues more than their stickier counterparts, and...

– University of California San Diego

Cancer Research, Dec-2020; T32AR060712; W911NF-17-1-0413; R01CA206880; R21CA217735; F32HL126406; 1651855; 1763132; 1763139; 15–172–45-IRG...


Shift in treatment modalities associated with improved outcomes in uveal melanoma patients with liver metastasis

New retrospective study indicates that the shift of treatment from systemic chemotherapies to liver-directed therapies provides survival benefits.

– Thomas Jefferson University

Cancers


Lower Survival in Patients with High BMI and HER2+ Metastatic Breast Cancer Treated with Pertuzumab and Trastuzumab

An international team of researchers found that high BMI correlates to lower survival in patients with HER2+ metastatic breast cancer, even among patients showing initial positive response to new anti-HER2 agents pertuzumab and trastuzumab.

– Sbarro Health Research Organization (SHRO)

Journal of Cellular Physiology


Less chemotherapy may have more benefit in rectal cancer

University of Colorado Cancer Center study presented at the 2020 Gastrointestinal Cancers Symposium shows patients with locally advanced rectal cancer receiving lower-than-recommended doses of neoadjuvant chemotherapy in fact saw their tumors shrink ...

– University of Colorado Cancer Center

2020 Gastrointestinal Cancers Symposium


Science Snapshot From Berkeley Lab - a biocompatible material that turns up the heat on antibacterial-resistant diseases

Scientists at Berkeley Lab’s Molecular Foundry have designed a biocompatible polymer that has the potential to advance photothermal therapy, a technique that deploys near-infrared light to combat antibacterial-resistant infections and cancer.

– Lawrence Berkeley National Laboratory

Angewandte Chemie, Oct-7-2019


Cheap nanoparticles stimulate immune response to cancer in the lab

University of Wisconsin–Madison researchers have developed nanoparticles that, in the lab, can activate immune responses to cancer cells. If they are shown to work as well in the body as they do in the lab, the nanoparticles might provide an effect...

– University of Wisconsin-Madison

Journal of the American Chemical Society Jan. 2, 2020


UCLA researchers find chronic inflammation contributes to cancer metastasis

The study reveals a detailed epigenetic mechanism for how interleukin-1-beta, a common cytokine that helps fight infections during inflammation, plays a critical role in cancer metastasis.

– University of California, Los Angeles (UCLA), Health Sciences

Scientific Reports


Cancer Experts and Features


Physicians and Regulators Must Act on NELSON Study published in NEJM to Support Widespread Lung Cancer Screening

The Dutch-Belgian Randomized Lung Cancer Screening Trial, known as the NELSON trial (de Koning et al), published Jan. 29 in NEJM, reconfirms that screening high-risk patients greatly reduces lung cancer deaths. Regulators and physicians should act t...

– American College of Radiology (ACR)

New England Journal of Medicine (NEJM)

Embargo expired on 29-Jan-2020 at 17:00 ET


NCCN Recognizes Progress on World Cancer Day while Highlighting Need for Better Global Access to High-Quality Care

February 4 is the 20th annual World Cancer Day. NCCN is commemorating its 25th anniversary year by looking back at the tremendous progress made against cancer over the past quarter-century and looking forward to further define and advance high-qualit...

– National Comprehensive Cancer Network® (NCCN®)

Embargo expired on 04-Feb-2020 at 00:05 ET


Diseases of the Colon and Rectum Journal February 2020 Video Abstracts and Editor Picks

Diseases of the Colon and Rectum Journal February 2020 Video Abstracts and Editor Picks

– Diseases of the Colon and Rectum Journal

Diseases of the Colon & Rectum Journal, February 2020


Diseases of the Colon and Rectum Journal January 2020 Video Abstracts and Editor Picks

Diseases of the Colon and Rectum Journal January 2020 Video Abstracts and Editor Picks

– Diseases of the Colon and Rectum Journal


You’ve survived cancer: what next?

On World Cancer Day, University of South Australia researchers are calling for more support for cancer survivors, who often feel the physical and mental impacts of their disease long after treatment has finished.

– University of South Australia


Vanderbilt-Ingram Cancer Center Patient First for New Cell Engineering Platform

VICC is the first cancer center to enroll a patient in a clinical trial for this new technology developed by SQZ Biotechnologies of Watertown, Massachusetts. The investigational product is generated from the company’s technology that uses high-spee...

– Vanderbilt University Medical Center


Vegetable Gardening to Grow Health

The Southwest Harvest for Health pilot study pairs cancer survivors with local master gardeners who have been trained in gardening techniques that address New Mexico’s growing challenges. The pair will create a vegetable garden at the survivor’s...

– University of New Mexico Comprehensive Cancer Center


The Medical Minute: Is ‘impossible’ meat too good to be true?

It sizzles on the grill. But does it fizzle in terms of nutrition? That’s the question when it comes to the new burgers made of plant-based meat substitutes that are flying off grocery store shelves and restaurant tables.

– Penn State Health


Tip Sheet: Tracking coronavirus, improving immunotherapies, cancer death rates decline, AAAS meeting and more

Summaries of recent Fred Hutch research studies, plus information on a press event at the upcoming AAAS annual meeting in Seattle.

– Fred Hutchinson Cancer Research Center


Expert Available to Discuss NELSON Trial and Lung Cancer Screening

– The Society of Thoracic Surgeons


Cancer Announcements


Well-Known Hematologist-Oncologist Leads Perlmutter Cancer Center’s New Location in Sunset Park, Expanding Care to Brooklyn Residents

NYU Langone hematologist-oncologist Dr. Rami K. Daya is leading renowned cancer experts at Perlmutter Cancer Center’s new Sunset Park location.

– NYU Langone Health


Women’s Heart Fund Launches ‘Community Conversations with the CDI’

The Women’s Heart Fund, a philanthropic arm of Hackensack Meridian Health Meridian Health Foundation, has announced that for its newest venture, the organization will sponsor ‘Community Conversations with the CDI,’ a women-focused, three-year l...

– Hackensack Meridian Health


Yale Cancer Center Awards for Clinical Excellence presented during annual Conclave

Debra Brandt, D.O. and Kevin Kim, M.D. were each honored with the Yale Cancer Center (YCC) Award for Clinical Excellence at YCC’s annual Conclave on Monday, January 13.

– Yale Cancer Center


Yan wins Yale Cancer Center Class of 1961 Cancer Research Award

Qin Yan, Ph.D., was presented with the Yale Cancer Center (YCC) Class of 1961 Cancer Research Award at YCC’s annual Conclave

– Yale Cancer Center


Lenox receives Yale Cancer Center Ruth McCorkle Oncology Advanced Practice Provider award

Raymond Lenox, APRN, was presented with the Yale Cancer Center Ruth McCorkle Oncology Advanced Practice Provider Award at YCC’s annual Conclave.

– Yale Cancer Center


Yale Cancer Center presents Research awards during annual Conclave

Yale Cancer Center (YCC) held its annual Conclave and award ceremony. The night celebrated the accomplishments of goals set for 2019 and honored faculty and staff with clinical and research prizes.

– Yale Cancer Center


Fred Hutch scientists host press event on future of medicine at AAAS annual meeting

Fred Hutchinson Cancer Research Center will host a press breakfast Feb. 14 at the annual meeting of the American Association for the Advancement of Science, to be held Feb. 13-16 in Seattle.

– Fred Hutchinson Cancer Research Center

AAAS Annual Meeting, Feb. 14, Washington State Convention Center


Putting Precision Oncology into Practice

Rush University Medical Center is the first health care organization to launch a genomic results module within an electronic medical record. While cancer cells contain the clues needed to identify specific treatments, few providers have the expertis...

– Rush University Medical Center


Robert Schreiber Joins the Ludwig Institute's Scientific Advisory Committee

Ludwig Cancer Research extends a warm welcome to Robert Schreiber, the newest member of the Scientific Advisory Committee of the Ludwig Institute for Cancer Research.

– Ludwig Cancer Research


$18 million gift will expand whole-person care for patients and families facing cancer

An $18 million commitment from the Simms/Mann Family Foundation will support UCLA’s expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.

– University of California, Los Angeles (UCLA), Health Sciences


Tackle Kids Cancer Receives Generous Donation from Corporate Partner Guardian Data Destruction

HACKENSACK, NJ – January 29, 2020 – Hackensack Meridian Health Hackensack University Medical Center Foundation is pleased to announce that Tackle Kids Cancer, a philanthropic program benefitting the Children’s Cancer Institute at Hackensack Mer...

– Hackensack Meridian Health


Ceevra mobile 3D visualization platform adopted by renowned urologic oncology surgeon Dr. James Porter

Ceevra, Inc., a San Francisco-based advanced visualization platform for surgeons, today announced that renowned urologic oncology surgeon, Dr. James Porter, has commercially adopted Ceevra’s mobile 3D visualization platform to help plan and perform...

– Ceevra

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 University of Wisconsin-Madison

 Penn State Health

 University of Texas M. D. Anderson Cancer Center

 University of California, Los Angeles (UCLA), Health Sciences

 Diseases of the Colon and Rectum Journal

 Lawrence Berkeley National Laboratory


Subscribe / Unsubscribe
Edit my preferences

© 2020 Newswise, Inc. All Rights Reserved.

265 Turkey Sag Trail Suite 102, #110 Palmyra VA 22963 | 434-296-9417

 Contact Us